Nucleophosmin 1 expression in acute myeloid leukemia

We studied the demographics and response to treatment of patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) between 1989 and 2000 in Teresina, Piauí,

Tuberculosis showed peripheral enhancement, frequently with a multilocular appearance, in 43 (78.2%) patients, whereas patients with leukemia (78.9% for acute myeloid leukemia and

The objective of this study was to evaluate the p53 protein expression in leukemias and the TP53 gene mutations in patients with chronic myeloid leukemia.. Peripheral blood and

The expression of the CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia.. Hematology and Oncology Department, Faculdade de Medicina de

PFS: progression-free survival; OS: overall survival; AML: acute myeloid leukemia; ALL: acute lymphoblastic leukemia; CR: complete remission; RR: response rate; CMML:

The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid

Indeterminate cell histiocytosis (ICH) is a rare proliferative disorder, in which the predominant cells share morphologic and immunophenotypic features from both Langerhans

AKT, AKT serine/threonine kinase; AML, acute myeloid leukemia; AMPK, AMP-activated protein kinase; ALL, acute lymphoblastic leukemia; B-ALL, B cell acute lymphoblastic leukemia;